Sequestration of Plasmodium falciparum-infected erythrocytes to the capillary endothelium can cause obstruction and localized tissue damage. Occlusion of vessels in falciparum malaria infection has been related to two properties of the parasite: adhesion to endothelial cells and rosette formation. Our study on P. falciparum isolates from Thailand producing variable numbers of rosettes suggests the involvement of rosettes in capillary blockage caused by direct adhesion of the rosette-forming infected erythrocytes to various target cells, e.g., live human umbilical vein endothelial cells, monocytes, and platelets. These rosettes did not bind Formalin-fixed target cells, nor did they bind to live or fixed C32 or G361 melanoma cells. Classification of the receptors involved in cytoadherence of endothelial cells and monocytes by specific antibody blocking and flow cytometry indicated that CD36 was involved in the adherence of monocytes but that other receptors besides CD36 may be involved in parasite adherence to endothelial cells. The cytoadherence of infected erythrocytes to monocytes was also associated with CD54 (ICAM-1). Further, differentiation of adherent monocytes resulted in an inversion of CD36 and CD54 levels on the cell surface which correlated with a decrease in surface binding of infected erythrocytes. This observation suggests that the state of cell activation and differentiation may also contribute to sequestration of parasites and to the pathogenesis of malaria.
Sequestration of Plasmodium falciparum-infected erythrocytes to the capillary endothelium can cause obstruction and localized tissue damage. Occlusion of vessels in falciparum malaria infection has been related to two properties of the parasite: adhesion to endothelial cells and rosette formation. Our study on P. falciparum isolates from Thailand producing variable numbers of rosettes suggests the involvement of rosettes in capillary blockage caused by direct adhesion of the rosette-forming infected erythrocytes to various target cells, e.g., live human umbilical vein endothelial cells, monocytes, and platelets. These rosettes did not bind Formalin-fixed target cells, nor did they bind to live or fixed C32 or G361 melanoma cells. Classification of the receptors involved in cytoadherence of endothelial cells and monocytes by specific antibody blocking and flow cytometry indicated that CD36 was involved in the adherence of monocytes but that other receptors besides CD36 may be involved in parasite adherence to endothelial cells. The cytoadherence of infected erythrocytes to monocytes was also associated with CD54 (ICAM-1). Further, differentiation of adherent monocytes resulted in an inversion of CD36 and CD54 levels on the cell surface which correlated with a decrease in surface binding of infected erythrocytes. This observation suggests that the state of cell activation and differentiation may also contribute to sequestration of parasites and to the pathogenesis of malaria.
Plasmodium falciparum may cause severe infection with high morbidity and mortality in both human and primate hosts (12, 13) . The precise mechanisms are unclear, but occlusion of blood vessels by P. falciparum-infected erythrocytes (RBC), especially in the brain, results in pathophysiological changes (5, 28, 29) , and delay in treatment may be fatal. The mechanism(s) of vascular occlusion by infected RBC appears to be related to the property of P. falciparum cytoadherence to endothelium in postcapillary venules (1, 17) . Recently, an ex vivo model showing vascular obstruction by rosette-forming P. falciparum-infected RBC was described (10) . Rosette formation, therefore, could be involved in sequestration-related obstruction in the host microvasculature and contribute to the pathogenesis of severe malaria. However, the importance of rosette-forming infected RBC in severe malaria in humans remains to be established. Studies on the cytoadherence of P. falciparuminfected RBC have involved a number of target cells derived from various human tissues, including umbilical vein endothelial cells (26) , amelanotic melanoma cells (22) , monocytes (3), platelets (15, 16) , and erythrocytes (6, 27) , that interact with infected RBC.
The mechanisms of binding to these target cells have been shown to involve a group of receptors on target cells and several parasite-derived protein ligands on the membrane of infected RBC (8) . Receptors that have been reported previously include CD36 (2, 3, 14, 18, 19) , intercellular adhesion molecule 1 (ICAM-1; also called CD54) (4) , and thrombospondin (20, 21) . A recent study demonstrated that the interaction between human infected RBC and normal RBC, rosette formation, is different from the interaction between * Corresponding author.
infected RBC and melanoma cells (27) , suggesting the presence of a distinct parasite ligand(s) or patterns of ligandreceptor interactions.
In this report, we describe the cytoadherence characteristics of two rosette-forming P. falciparum isolates and a nonrosetting isolate with various target cells. The rosetting P. falciparum parasites bound readily to fresh endothelial cells and monocytes both as rosettes and as individual infected RBC but did not bind to melanoma cells. The nonrosetting parasite did bind to the melanoma cell lines. Receptors involved in the binding of these infected RBC were investigated. Correlations between expression of markers on target cells and the binding efficiency of each target cell were assessed. Our observations support a role for CD36 as a receptor for infected RBC binding to human monocytes but not endothelial cells and suggest the presence of as yet unidentified receptors on endothelial cells that may contribute to the pathophysiological consequences of parasite sequestration in malaria.
MATERIALS AND METHODS
Antibodies and reagent. Monoclonal antibody (MAb) to CD36 (OKM5; immunoglobulin Gl [IgGl]) was purchased from Ortho Pharmaceuticals, Raritan, N.J.; MAb to ICAM-1 (BMS101, IgG2a) was from Bender Med System, Vienna, Austria; MAb to ICAM-1 (LB-2, IgG2b), CD14, and HLA-DR and mouse IgGl and IgG2a MAb were from Becton Dickinson Immunocytometry Systems; and goat antiserum to human factor 8 was from ICN Biomedicals Inc., Costa Mesa, Calif. The F(ab')2 fraction of rabbit anti-mouse or anti-goat immunoglobulin conjugated with fluorescein isothiocyanate (FITC) was obtained from Dako-4484 UDOMSANGPETCH ET AL. patts a/s. Purified soluble CD36 was a gift from C. Ockenhouse, Washington, D.C.
Parasites. The Thai P. falciparum isolates TM178R and TM267R from Chantaburi and ND9 from Prajeenburi were maintained as previously described (24) with human group 0 RBC. Cells were cultured in medium RPMI 1640 (Seromed, Biochrom, Germany) supplemented with 2 mM glutamine, 25 mM HEPES (N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid), 10% human serum, and 20 ,g of gentamicin per ml (pH 7.4) at 37°C in a 5% CO2 atmosphere. Cultures were maintained at 15 to 20% parasitized RBC (PRBC) and 3% hematocrit (Hct) in order to perform cytoadherence assays without agitation and yet obtain appropriate contact between target cells and PRBC.
Enumeration of rosette formation. One drop of P. falciparum culture mounted with a coverslip on a glass slide was examined by light microscopy. Rosette formation was characterized by a PRBC associated with two or more uninfected RBC. The number of rosettes in 500 PRBC containing malarial pigment was counted and calculated as a percentage of the rosettes in the culture.
Target cell preparation. Human umbilical vein endothelial cells were isolated and maintained in culture as described previously (9) and used from passages 2 through 4. For identification of endothelial cells, the cells from passage 3 were stained with antiserum to human factor 8 and FITC conjugate and analyzed by flow cytometry. The result showed that >99% of these cells were of the factor 8-positive phenotype. The cells were kept in M199 medium (Gibco Limited, Paisley, Scotland) supplemented with 200 ,ug of endothelial cell growth factor (Biochemical Supplies Co. Ltd., Bethesda, Mass.) per ml, 2 mM glutamine, 20% fetal calf serum, and 20 ,ug of gentamicin per ml (pH 7.4) at 37°C in a 5% CO2 atmosphere. The endothelial cells were passaged at 80% confluence by treatment with 20 mM EDTA in phosphate-buffered saline (PBS), collection in suspension, and washing in medium. The cells were then resuspended with culture medium and grown to 2 x 104 cells per coverslip for 18 to 20 h.
Two melanoma cell lines, C32 and G361, were maintained in RPMI 1640 medium supplemented with 2 mM glutamine, 10% fetal calf serum, and 20 ,ug of gentamicin per ml (pH 7.4) at 37°C in a 5% CO2 atmosphere. These cell lines were grown to 2 x 105 cells per coverslip for 18 to 20 h.
Mononuclear cells were separated by overlayering heparinized blood on Lymphoprep density gradients (Nycomed AS, Oslo, Norway) and centrifugation for 30 min at 600 x g at room temperature. Cells in the interface were collected, washed twice in RPMI 1640, pH 7.4, and then resuspended in RPMI medium (pH 7.4) containing 3% AB' serum. Adherent monocytes were obtained by incubating the mononuclear cell fraction at 1 x 106 to 3 x 106 cells per coverslip for 30 min at 37°C in a 5% CO2 atmosphere. The nonadherent cells were rinsed off by flushing the coverslip with incubating medium, and the adherent cells were kept in the medium and used in cytoadherence assays within 3 h after preparation. To check the purity of adherent monocytes, the adherent cells were scraped loose from a petri dish and stained with MAb to CD14 and FITC conjugate. Flow cytometric analysis showed that 76 to 86% of these cells were CD14+.
Platelets were obtained by diluting platelet-rich plasma 1:1 (vol/vol) with RPMI medium (pH 7.4) and incubating 200 pl per coverslip at 37°C for 30 min. The coverslips were then rinsed with incubating medium.
All target cells were kept in incubating medium under culture conditions until used or fixed with 1% Formalin for 1 h, washed, and kept in PBS until used.
Cytoadherence assay. One hundred and fifty microliters of parasites having at least 10% trophozoite-or schizontinfected PRBC (T/S-PRBC), 3% Hct, in malaria culture medium was incubated on a coverslip of the target cells at 37°C for 1 h without agitation. The coverslips were rinsed with PBS, fixed briefly with 1% glutaraldehyde, washed, and stained with Giemsa for examination by light microscopy. The numbers of rosetting and nonrosetting PRBC bound per 100 target cells were calculated from the total number of PRBC among 500 target cells, both bound and not bound to PRBC.
To identify platelets, after cytoadherence was performed and the coverslip was fixed with glutaraldehyde and dried as above, the coverslip was then treated briefly with cold acetone, rinsed with PBS, stained with OKM5 MAb (2 ,g/ml) and FITC conjugate, washed, mounted on a glass slide with 50% glycerol containing 10 ,ug of ethidium bromide per ml, and examined by UV microscopy.
On some occasions, the assay was performed with TM267R cultured at 1% Hct containing 2 to 3% T/S-PRBC. Some assays were also performed with rosetting-positive (R+) and -negative (R-) phenotypes of TM267R, which were obtained by enrichment as described previously (28) (Fig. 1) at various percentages. The mean percentage (range) of rosette formation by TM178R and TM267R in four observations was 6% (4 to 9%) and 51% (39 to 64%), respectively. These strains showed a wide range in intrinsic capacity to form rosettes, as suggested by the differences between the two isolates, which have been maintained in culture for 1 year (TM178R) or 5 months (TM267R). A nonrosette-forming isolate, ND9, maintained for 8 months in culture, was examined and included for comparison.
Cytoadherence characteristics of PRBC. Previous work on the cytoadherence to target cells of nonrosetting P. falciparum-infected RBC showed that cytoadherence was the result of interaction between parasite ligands and receptors on the target cells. We investigated whether P. falciparum from areas where it is endemic which formed rosettes during in vitro culture would also interact with other target cells despite the fact that the central PRBC was physically constrained by surrounding uninfected RBC. An in vitro cytoadherence assay with human umbilical vein endothelial cells as targets showed that these rosetting parasites were able to bind fresh but not Formalin-fixed endothelial cells (Table 1 and Fig. 2A) with the above conditions, when the assay was performed with TM267R containing 2 to 3% T/S-PRBC at 1% Hct, the number of PRBC (as rosettes [R+] 
or as nonrosettes [R-])
bound to target cells was reduced; 81 R+ and 119 R-per 100 endothelial cells and 34 R+ and 36 R-per 100 adherent monocytes). When rosetting-positive and -negative phenotypes of TM267R were enriched in two separate fractions (85% R+ and 98% R-) and used for cytoadherence to endothelial cells and adherent monocytes at 2 to 3% T/S-PRBC with 1% Hct, a marked reduction in the number of PRBC bound to both target cells was observed (31 R+ and 19 R-per 100 endothelial cells; 5 R+ and 25 R-per 100 adherent monocytes). Further investigation showed that fresh but not Formalin-fixed monocytes and platelets obtained from peripheral blood bound rosettes from the two isolates of P. falciparum (Fig. 2B and C) . Individual PRBC from these rosette-forming isolates reacted similarly with fresh and fixed endothelial cells and monocytes (Table 1) .
Similar results were obtained with the nonrosetting isolate ND9, although it bound to fixed monocytes but not endothelial cells.
Under various conditions, either high or low percent T/S-PRBC and Hct, we observed that neither of the two rosetting P. falciparum isolates showed binding to C32 melanoma cells or to G361 cells ( Table 1) . As shown in Table  1 , the non-rosette-forming PRBC from ND9 bound to the C32 melanoma cells, the G361 cell line, and monocytes.
We also observed the ability of R+ and R-binding to CD36. The levels of R+ and R-binding were 24 A. BMS101 showed no substantial blocking of PRBC binding (less than 20% inhibition at 4 ,ug of the MAb per ml) (Fig.  3A) . Another MAb to ICAM-1 (LB-2) also did not block PRBC binding (data not shown). With monocytes as targets, both MAb OKM5 and BMS101 were observed to block the binding of PRBC in a dose-dependent fashion (Fig. 3B) . MAb BMS101 had a stronger inhibitory effect on binding with monocytes (60% inhibition at 4 ,ug/ml) than did MAb OKM5 (35% inhibition at 4 ,ugIml). The combination of MAb OKMS and BMS101 increased inhibition of binding of PRBC to monocytes (Fig. 3B) (Fig. 4A) . Greater than 80% of the adherent monocytes expressed high levels of CD36 staining and moderate levels of ICAM-1 staining (Fig. 4B) . C32 melanoma cells expressed ICAM-1 at very high levels, whereas 52% of these cells showed little expression of CD36, as measured by immunofluorescence (Fig. 4C) . G361 cells did not express CD36, whereas 62% of these cells expressed ICAM-1 at low levels (Fig. 4D) .
Monocyte differentiation and parasite cytoadherence. Using flow cytometry, we observed that freshly adherent monocytes expressed higher levels of CD36 than of ICAM-1, as measured with MAb OKM5 and BMS101, respectively ( 5A). At 2 h, the intensity of CD36 staining increased slightly (Fig. SB) but then decreased thereafter, until by 4 h, it was comparable to the intensity of ICAM-1 staining (Fig. 5C) . At 24 h after adherence, the differentiated monocytes/macrophages showed a marked decrease in CD36 intensity relative to ICAM-1, with an overall increase in ICAM-1 (Fig. SD) just the opposite of the relationship seen at 0 h. When cytoadherence of PRBC with these differentiating monocytes/macrophages was studied, we found that binding of the PRBC correlated well with the level of CD36 expression. By examining 500 monocytes/macrophages, both bound and not bound to PRBC, maximal binding of infected RBC was observed after 2 h of monocyte/macrophage differentiation, during which CD36 expression was maximal and the ICAM-1 (CD54) level remained low (Fig. 5B) . Decreased binding of PRBC was observed after 4 h until at 24 h, when CD36 was at a minimum level but CD54 was at a maximum level (Fig. SD) There was no significant inhibition of binding of PRBC to endothelial cells by either of the two MAb, nor could any MAb reverse cytoadherence to the endothelial cells. Inhibition by the OKM5 MAb was not expected, since endothelial cells do not react with this MAb. Our finding is consistent with a previous observation (7) which suggests that other receptors may be important in the adherence of PRBC to the vascular endothelium. For monocytes, however, inhibition of PRBC binding was increased in a dose-dependent manner with MAb to CD36 or ICAM-1. The inhibitory effect of these MAb was additive when the two MAb were combined in the assay; however, complete inhibition was not achieved. With another MAb to ICAM-1 (LB-2; Becton Dickinson) at a range of concentrations similar to those of MAb BMS101, we found no inhibitory effect on either endothelial cells or monocytes. These results suggest that MAb to ICAM-1 obtained from different producing cell clones recognize different epitopes on the ICAM-1 molecule and hence have variable cytoadherence-inhibitory effects. The results also suggest that other receptors are involved in the adherence of PRBC to these target cells.
We interpret these observations with regard to the two rosetting P. falciparum isolates as follows. Although ICAM-1 was present on all four target cells, ICAM-1 was not by itself sufficient for binding of PRBC to endothelial cells. Furthermore, even though ICAM-1 was present on C32 and G361 cells, in our study with the rosette-forming P. falciparum TM267R and TM178R isolates, there was no binding of PRBC to these target cells. ICAM-1 did appear to contribute to cytoadherence with monocytes. CD36 appeared to be important on monocytes and possibly C32 melanoma cells. However, CD36, as defined by reactivity with the OKM5 MAb, appeared not to be involved in binding of PRBC to endothelial cells.
Binding of PRBC may vary with the functional status of receptors, depending on target cell type, state of differentiation, and physiological conditions. Our experiments with adherent monocytes/macrophages which showed up-and down-regulation of CD36 and ICAM-1 expression with increasing time after adherence indicated that the state of cell activation or differentiation may contribute to the relative availability of a specific receptor for binding of PRBC. These observations suggest the need for further investigation of the receptors and host factors involved in sequestration of P. falciparum and on the involvement of rosette formation in the pathogenesis of severe malaria.
